This is the current revision of this page, as edited by Maxim Masiutin(talk | contribs) at 12:58, 14 January 2024(Add: s2cid, bibcode. Added the cs1 style template to denote Vancouver ("vanc") citation style, because references contain "vauthors" attribute to specify the list of authors.). The present address (URL) is a permanent link to this version.
Revision as of 12:58, 14 January 2024 by Maxim Masiutin(talk | contribs)(Add: s2cid, bibcode. Added the cs1 style template to denote Vancouver ("vanc") citation style, because references contain "vauthors" attribute to specify the list of authors.)
Ono K, Uzawa K, Nakatsuru M, Shiiba M, Mochida Y, Tada A, Bukawa H, Miyakawa A, Yokoe H, Tanzawa H (2004). "Down-regulation of FEZ1/LZTS1 gene with frequent loss of heterozygosity in oral squamous cell carcinomas". Int. J. Oncol. 23 (2): 297–302. doi:10.3892/ijo.23.2.297. PMID12851677.
Hawkins GA, Mychaleckyj JC, Zheng SL, Faith DA, Kelly B, Isaacs SD, Wiley KE, Chang BL, Ewing CM, Bujnovszky P, Bleecker ER, Walsh PC, Meyers DA, Isaacs WB, Xu J (2002). "Germline sequence variants of the LZTS1 gene are associated with prostate cancer risk". Cancer Genet. Cytogenet. 137 (1): 1–7. doi:10.1016/S0165-4608(02)00549-6. PMID12377406.
Cabeza-Arvelaiz Y, Sepulveda JL, Lebovitz RM, Thompson TC, Chinault AC (2001). "Functional identification of LZTS1 as a candidate prostate tumor suppressor gene on human chromosome 8p22". Oncogene. 20 (31): 4169–79. doi:10.1038/sj.onc.1204539. PMID11464283. S2CID38760860.